Ignite Creation Date:
2025-12-18 @ 9:11 AM
Ignite Modification Date:
2025-12-23 @ 5:41 PM
Study NCT ID:
NCT04631549
Status:
None
Last Update Posted:
2022-12-01 00:00:00
First Post:
2020-11-13 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants
Sponsor:
None
Organization:
Study Overview
Official Title:
A Multi-center, Non-randomized, Open-label, Parallel Controlled Pharmacokinetic Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants
Status:
None
Status Verified Date:
2022-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate SHR3680 in participants with different levels of liver function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: